View in EDS PDF Full Text

White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Saved in:
Bibliographic Details
Title: White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
Authors: Provenzano FA; Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA., Muraskin J, Tosto G, Narkhede A, Wasserman BT, Griffith EY, Guzman VA, Meier IB, Zimmerman ME, Brickman AM
Corporate Authors: Alzheimer's Disease Neuroimaging Initiative
Source: JAMA neurology [JAMA Neurol] 2013 Apr; Vol. 70 (4), pp. 455-61.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23420027
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Provenzano+FA%22">Provenzano FA</searchLink>; Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.<br /><searchLink fieldCode="AU" term="%22Muraskin+J%22">Muraskin J</searchLink><br /><searchLink fieldCode="AU" term="%22Tosto+G%22">Tosto G</searchLink><br /><searchLink fieldCode="AU" term="%22Narkhede+A%22">Narkhede A</searchLink><br /><searchLink fieldCode="AU" term="%22Wasserman+BT%22">Wasserman BT</searchLink><br /><searchLink fieldCode="AU" term="%22Griffith+EY%22">Griffith EY</searchLink><br /><searchLink fieldCode="AU" term="%22Guzman+VA%22">Guzman VA</searchLink><br /><searchLink fieldCode="AU" term="%22Meier+IB%22">Meier IB</searchLink><br /><searchLink fieldCode="AU" term="%22Zimmerman+ME%22">Zimmerman ME</searchLink><br /><searchLink fieldCode="AU" term="%22Brickman+AM%22">Brickman AM</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Alzheimer's+Disease+Neuroimaging+Initiative%22">Alzheimer's Disease Neuroimaging Initiative</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589536%22">JAMA neurology</searchLink> [JAMA Neurol] 2013 Apr; Vol. 70 (4), pp. 455-61.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589536 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686149%22">21686149 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Neurol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23420027
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaneurol.2013.1321
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 455
    Titles:
      – TitleFull: White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Provenzano FA
      – PersonEntity:
          Name:
            NameFull: Muraskin J
      – PersonEntity:
          Name:
            NameFull: Tosto G
      – PersonEntity:
          Name:
            NameFull: Narkhede A
      – PersonEntity:
          Name:
            NameFull: Wasserman BT
      – PersonEntity:
          Name:
            NameFull: Griffith EY
      – PersonEntity:
          Name:
            NameFull: Guzman VA
      – PersonEntity:
          Name:
            NameFull: Meier IB
      – PersonEntity:
          Name:
            NameFull: Zimmerman ME
      – PersonEntity:
          Name:
            NameFull: Brickman AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2013 Apr
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6157
          Numbering:
            – Type: volume
              Value: 70
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: JAMA neurology
              Type: main
ResultId 1